Synopsys Posts Financial Results for Third Quarter Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St futures gain as chip stocks extend recovery; earnings in focus
- Oil prices rise nearly 2% on fresh attacks by US and Iran
- Chip stocks extend global rebound following last week's rout
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- Danaher shares tumble despite earnings beat
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Synopsys (SNPS) PT Raised to $160 at RBC Capital
August 22, 2019 6:24 AM EDTRBC Capital analyst Mitch Steves raised the price target on Synopsys (NASDAQ: SNPS) to $160.00 (from $158.00) while maintaining a Top Pick rating.
Steves commented, "Synopsys reported a beat-and-raise quarter across all metrics. We see potential for $6.50 in EPS out in 2021E and remain bullish on the sector, management team, and fundamentals."
... MoreSynopsys (SNPS) Tops Q3 EPS by 8c, Revenues Beat; Offers Q4 & FY19 EPS/Revenue Guidance Above Consensus
August 21, 2019 4:08 PM EDTSynopsys (NASDAQ: SNPS) reported Q3 EPS of $1.18, $0.08 better than the analyst estimate of $1.10. Revenue for the quarter came in at $853 million versus the consensus estimate of $831.02 million.
"Synopsys continues to execute very well and delivered excellent third fiscal quarter revenue, operating... More
